Chroma Medicine

About:

Chroma Medicine is a new genomic medicine company working on epigenetic editing.

Top Investors: Alexandria Venture Investments, Wellington Management, ARCH Venture Partners, Cormorant Asset Management, Google Ventures

Description:

Chroma Medicine is a new genomic medicine company working on epigenetic editing. Chroma Medicine is pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, to revolutionize the treatment of genetically driven diseases. Chroma Medicine was established in 2021 in Cambridge, Massachusetts.

Total Funding Amount:

$260M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)chromamedicine.com

Founders:

Angelo Lombardo, David R. Liu, J. Keith Joung, Jonathan Weissman, Luigi Naldini, Luke Gilbert

Number of Employees:

101-250

Last Funding Date:

2023-03-01

IPO Status:

Private

Industries: